Brent Siler

Brent Siler has experience in representing public companies, soon-to-be-public companies and underwriters. His clients are focused mostly in technology and the life sciences, and he assists them in connection with registered public offerings, private financings, public company securities compliance, corporate governance, M&A and general corporate counseling. Brent has represented issuers and underwriters in more than 75 public offerings, including 50+ IPOs.

Representative company-side IPOs:  Entasis, Clearside, Aclaris, KemPharm, 2U, GlycoMimetics, Trevena, ChannelAdvisor, LipoScience, Millennial Media,  Blackboard, SRA International, OPNET Technologies, Sucampo Pharmaceuticals, Eclipsys, OTG Software, Career Builder, Distributed Energy Systems and Edison Schools.

Brent has also represented underwriters such as Bank of America Merrill Lynch, Cowen, Citigroup, Credit Suisse, Deutsche Bank, Goldman Sachs, Jefferies, J.P. Morgan, Leerink, Morgan Stanley, Needham, Oppenheimer, Piper Jaffray, Stifel Nicolaus, Wells Fargo and William Blair in several IPOs, including U.S. listings for a number of foreign private issuers:  LogicBio, Liquidia, MeiraGTX, Scholar Rock, Apellis, OrthoPediatrics, NuCana, Argenx, Verona, Yext, Valeritas, Tabula Rasa, Novan, Strongbridge, Chiasma, Catabasis, Vascular Biogenics, T2, Epizyme, Onconova, TetraLogic, Eleven Biotherapeutics, Egalet, Rosetta Stone.